Literature DB >> 15783163

Solution structure of a beta-peptide ligand for hDM2.

Joshua A Kritzer1, Michael E Hodsdon, Alanna Schepartz.   

Abstract

We recently reported a beta-peptide foldamer, beta53-1, that folds into a 14-helix in aqueous solution, binds the oncoprotein hDM2 with submicromolar affinity, and potently inhibits the interaction of hDM2 with a peptide derived from the activation domain of p53 (p53AD). Here, we present the solution structure of beta53-1 in methanol. Details of the structure illustrate fundamental and novel elements of beta-peptide folding and recognition. These elements include the detailed arrangement of a complex, 14-helix-stabilizing salt bridge on one helical face, and a unique "wedge into cleft" packing interaction along a second. The structure also reveals how a subtle distortion in the beta53-1 14-helix geometry alters the presentation of its recognition epitope, rendering it particularly well suited for alpha-helix mimicry. The solution structure of beta53-1 demonstrates that well folded beta-peptide oligomers can effectively present an extended, highly variable surface that could be used as a general platform for targeting critical protein-protein interfaces.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15783163      PMCID: PMC2857645          DOI: 10.1021/ja042933r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Structural characterisation and functional significance of transient protein-protein interactions.

Authors:  Irene M A Nooren; Janet M Thornton
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

2.  Helical beta-peptide inhibitors of the p53-hDM2 interaction.

Authors:  Joshua A Kritzer; James D Lear; Michael E Hodsdon; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2004-08-11       Impact factor: 15.419

3.  Helix macrodipole control of beta 3 peptide 14-helix stability in water.

Authors:  Scott A Hart; Adilah B F Bahadoor; Erin E Matthews; Xiaoyan J Qiu; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2003-04-09       Impact factor: 15.419

4.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

Review 5.  The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.

Authors:  Dieter Seebach; Albert K Beck; Daniel J Bierbaum
Journal:  Chem Biodivers       Date:  2004-08       Impact factor: 2.408

Review 6.  Stability of alpha-helices.

Authors:  A Chakrabartty; R L Baldwin
Journal:  Adv Protein Chem       Date:  1995

7.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

8.  Long-range interactions stabilize the fold of a non-natural oligomer.

Authors:  Richard P Cheng; William F DeGrado
Journal:  J Am Chem Soc       Date:  2002-10-02       Impact factor: 15.419

9.  Relationship between side chain structure and 14-helix stability of beta3-peptides in water.

Authors:  Joshua A Kritzer; Julian Tirado-Rives; Scott A Hart; James D Lear; William L Jorgensen; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2005-01-12       Impact factor: 15.419

10.  Use of a retroinverso p53 peptide as an inhibitor of MDM2.

Authors:  Kaori Sakurai; Hak Suk Chung; Daniel Kahne
Journal:  J Am Chem Soc       Date:  2004-12-22       Impact factor: 15.419

View more
  20 in total

1.  beta-Peptides as inhibitors of protein-protein interactions.

Authors:  Joshua A Kritzer; Olen M Stephens; Danielle A Guarracino; Samuel K Reznik; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

2.  A rapid library screen for tailoring beta-peptide structure and function.

Authors:  Joshua A Kritzer; Nathan W Luedtke; Elizabeth A Harker; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2005-10-26       Impact factor: 15.419

Review 3.  Foldamers as versatile frameworks for the design and evolution of function.

Authors:  Catherine M Goodman; Sungwook Choi; Scott Shandler; William F DeGrado
Journal:  Nat Chem Biol       Date:  2007-05       Impact factor: 15.040

4.  Beta-peptides with improved affinity for hDM2 and hDMX.

Authors:  Elizabeth A Harker; Douglas S Daniels; Danielle A Guarracino; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2009-01-23       Impact factor: 3.641

5.  Inhibiting HIV fusion with a beta-peptide foldamer.

Authors:  Olen M Stephens; Sunghwan Kim; Brett D Welch; Michael E Hodsdon; Michael S Kay; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2005-09-28       Impact factor: 15.419

6.  Biophysical and structural characterization of a robust octameric beta-peptide bundle.

Authors:  Jessica L Goodman; E James Petersson; Douglas S Daniels; Jade X Qiu; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2007-11-07       Impact factor: 15.419

7.  Identification of a beta3-peptide HIV fusion inhibitor with improved potency in live cells.

Authors:  Arjel D Bautista; Olen M Stephens; Ligong Wang; Robert A Domaoal; Karen S Anderson; Alanna Schepartz
Journal:  Bioorg Med Chem Lett       Date:  2009-05-15       Impact factor: 2.823

8.  Computationally designed peptide inhibitors of the ubiquitin E3 ligase SCF(Fbx4).

Authors:  Junglim Lee; Deanne W Sammond; Zeno Fiorini; Jonel P Saludes; Michael G Resch; Bing Hao; Wei Wang; Hang Yin; Xuedong Liu
Journal:  Chembiochem       Date:  2013-02-11       Impact factor: 3.164

9.  Helical 1:1 α/Sulfono-γ-AA Heterogeneous Peptides with Antibacterial Activity.

Authors:  Fengyu She; Alekhya Nimmagadda; Peng Teng; Ma Su; Xiaobing Zuo; Jianfeng Cai
Journal:  Biomacromolecules       Date:  2016-04-13       Impact factor: 6.988

10.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.